임상 시험 검색 : MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q1w regime
총 1 건
이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.
스폰서 및 공동 작업자
- Yong-Hee Park
- Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, Shenzhen
- Dr. med. Julius Dengler
- Santosh University
- Eureka(Beijing) Biotechnology Co., Ltd.
- Seoul Clinical Laboratories
- University College of Osteopathy
- Dr.Ahmad Keelani
- ISTITUTO KURZ ITALIA S.R.L.
- Prana Biotechnology Limited
- Minovia Therapeutics Ltd.
- McMaster Children's Hospital (McMaster University)
- AbbVie Deutschland GmbH & Co KG (funding)
- Hammel Neurorehabilitation Centre and University Research Clinic
- The Kirby Institute, University of New South Wales
- HotSpot Therapeutics, Inc
- Nuvo Research GmbH
- Dr Stephen Vreden (Foundation for Scientific Research Suriname : SWOS)
- British Red Cross
- The Society for the Relief of Disabled Children, Hong Kong
- 전체 목록보기
CROs by country
- Contract Research Organizations in Colombia
- Contract Research Organizations in Finland
- Contract Research Organizations in Gambia
- Contract Research Organizations in Germany
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Latvia
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Morocco
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in South Africa
- Contract Research Organizations in South Korea
- Contract Research Organizations in Switzerland
- CRO list by country